Literature DB >> 19369195

Large-scale proteomics analysis of the human kinome.

Felix S Oppermann1, Florian Gnad, Jesper V Olsen, Renate Hornberger, Zoltán Greff, György Kéri, Matthias Mann, Henrik Daub.   

Abstract

Members of the human protein kinase superfamily are the major regulatory enzymes involved in the activity control of eukaryotic signal transduction pathways. As protein kinases reside at the nodes of phosphorylation-based signal transmission, comprehensive analysis of their cellular expression and site-specific phosphorylation can provide important insights into the architecture and functionality of signaling networks. However, in global proteome studies, low cellular abundance of protein kinases often results in rather minor peptide species that are occluded by a vast excess of peptides from other cellular proteins. These analytical limitations create a rationale for kinome-wide enrichment of protein kinases prior to mass spectrometry analysis. Here, we employed stable isotope labeling by amino acids in cell culture (SILAC) to compare the binding characteristics of three kinase-selective affinity resins by quantitative mass spectrometry. The evaluated pre-fractionation tools possessed pyrido[2,3-d]pyrimidine-based kinase inhibitors as immobilized capture ligands and retained considerable subsets of the human kinome. Based on these results, an affinity resin displaying the broadly selective kinase ligand VI16832 was employed to quantify the relative expression of more than 170 protein kinases across three different, SILAC-encoded cancer cell lines. These experiments demonstrated the feasibility of comparative kinome profiling in a compact experimental format. Interestingly, we found high levels of cytoplasmic and low levels of receptor tyrosine kinases in MV4-11 leukemia cells compared with the adherent cancer lines HCT116 and MDA-MB-435S. The VI16832 resin was further exploited to pre-fractionate kinases for targeted phosphoproteomics analysis, which revealed about 1200 distinct phosphorylation sites on more than 200 protein kinases. This hitherto largest survey of site-specific phosphorylation across the kinome significantly expands the basis for functional follow-up studies on protein kinase regulation. In conclusion, the straightforward experimental procedures described here enable different implementations of kinase-selective proteomics with considerable potential for future signal transduction and kinase drug target analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369195      PMCID: PMC2709199          DOI: 10.1074/mcp.M800588-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  47 in total

1.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

Authors:  Klaus Godl; Josef Wissing; Alexander Kurtenbach; Peter Habenberger; Stephanie Blencke; Heidrun Gutbrod; Kostadinos Salassidis; Matthias Stein-Gerlach; Andrea Missio; Matt Cotten; Henrik Daub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

2.  Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.

Authors:  Stephanie Blencke; Birgit Zech; Ola Engkvist; Zoltán Greff; László Orfi; Zoltán Horváth; György Kéri; Axel Ullrich; Henrik Daub
Journal:  Chem Biol       Date:  2004-05

3.  Large-scale characterization of HeLa cell nuclear phosphoproteins.

Authors:  Sean A Beausoleil; Mark Jedrychowski; Daniel Schwartz; Joshua E Elias; Judit Villén; Jiaxu Li; Martin A Cohn; Lewis C Cantley; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

Review 4.  Regulation of protein kinases; controlling activity through activation segment conformation.

Authors:  Brad Nolen; Susan Taylor; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

5.  Cellular targets of gefitinib.

Authors:  Dirk Brehmer; Zoltán Greff; Klaus Godl; Stephanie Blencke; Alexander Kurtenbach; Martina Weber; Stefan Müller; Bert Klebl; Matt Cotten; György Kéri; Josef Wissing; Henrik Daub
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

Review 6.  Tyrosine kinases as targets for cancer therapy.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

7.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

8.  Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns.

Authors:  Martin R Larsen; Tine E Thingholm; Ole N Jensen; Peter Roepstorff; Thomas J D Jørgensen
Journal:  Mol Cell Proteomics       Date:  2005-04-27       Impact factor: 5.911

9.  Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns.

Authors:  Martijn W H Pinkse; Pauliina M Uitto; Martijn J Hilhorst; Bert Ooms; Albert J R Heck
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

10.  Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors.

Authors:  Josef Wissing; Klaus Godl; Dirk Brehmer; Stephanie Blencke; Martina Weber; Peter Habenberger; Matthias Stein-Gerlach; Andrea Missio; Matt Cotten; Stefan Müller; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2004-10-08       Impact factor: 5.911

View more
  132 in total

1.  Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Eugenio Barone; Marzia Perluigi; Chiara Cini; Cesare Mancuso; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

Review 2.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

3.  Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin.

Authors:  Ryan J Austin; Heidi M Smidansky; Carly A Holstein; Deborah K Chang; Angela Epp; Neil C Josephson; Daniel B Martin
Journal:  Proteomics       Date:  2011-12-12       Impact factor: 3.984

Review 4.  The role of targeted chemical proteomics in pharmacology.

Authors:  Chris W Sutton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  SILACtor: software to enable dynamic SILAC studies.

Authors:  Michael R Hoopmann; Juan D Chavez; James E Bruce
Journal:  Anal Chem       Date:  2011-10-27       Impact factor: 6.986

Review 6.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.

Authors:  Walter Kolch; Andrew Pitt
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

Review 7.  A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation.

Authors:  Tracey A Dobbs; John A Tainer; Susan P Lees-Miller
Journal:  DNA Repair (Amst)       Date:  2010-10-28

8.  Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7.

Authors:  Kathryn M Taylor; Stephen Hiscox; Robert I Nicholson; Christer Hogstrand; Peter Kille
Journal:  Sci Signal       Date:  2012-02-07       Impact factor: 8.192

9.  Identification and characterization of a novel phosphoregulatory site on cyclin-dependent kinase 5.

Authors:  Brett Lee Roach; Jordan Matthew Ngo; Clariss Limso; Koyinsola Bolutife Oloja; Deepali Bhandari
Journal:  Biochem Biophys Res Commun       Date:  2018-09-11       Impact factor: 3.575

10.  A High-Throughput Targeted Proteomic Approach for Comprehensive Profiling of Methylglyoxal-Induced Perturbations of the Human Kinome.

Authors:  Weili Miao; Yongsheng Xiao; Lei Guo; Xiaogang Jiang; Ming Huang; Yinsheng Wang
Journal:  Anal Chem       Date:  2016-09-22       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.